V$AR_03
|
AR
|
14.1
|
2.39E−02
|
Tumour promoting [23]
|
Tumour promoting [24]
|
V$TFIIA_Q6
|
GTF2A1/GTF2A2
|
8.5
|
1.25E−02
|
General enhancement of gene transcription [25]
|
–
|
V$PR_01
|
PGR
|
7.1
|
5.47E−02
|
Tumour promoting [26]
|
Unclear [27]
|
V$HES1_Q2
|
HES1
|
7.1
|
1.79E−02
|
Tumour promoting [28]
|
Unknown
|
V$ZNF219_01
|
ZNF219
|
4.4
|
3.10E−14
|
Unknown
|
Unknown
|
V$AREB6_03
|
ZEB1
|
4
|
4.24E−03
|
Tumour promoting [29]
|
Tumour promoting [30, 31]
|
V$GCNF_01
|
NR6A1
|
3.2
|
2.99E−02
|
Tumour promoting [32]
|
Unknown
|
V$MAZR_01
|
PATZ1
|
2.7
|
2.16E−50
|
Tumour promoting [33]
|
Unknown
|
V$PAX4_04
|
PAX4
|
2.7
|
3.70E−02
|
Cell proliferation/survival promoting or tumour suppressing in different contexts [34]
|
Unknown
|
V$UF1H3BETA_Q6
|
UF1-HNF3B (not further identified)
|
2.6
|
3.09E−74
|
–
|
–
|
V$CACBINDINGPROTEIN_Q6
|
CAC-binding protein (not further identified)
|
2.5
|
1.87E−26
|
–
|
–
|
V$MTF1_Q4
|
MTF1
|
2.5
|
3.30E−04
|
Tumour promoting [35]
|
Unknown
|